|
Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
|
12 Months Ended |
|
Dec. 31, 2011
|
Dec. 31, 2010
|
Dec. 31, 2009
|
| Cash flows from operating activities: |
|
|
|
| Net income (loss) |
$ 15,051 |
$ (56,909) |
$ (16,821) |
| Adjustments to reconcile net income (loss) to net cash used in operating activities: |
|
|
|
| Depreciation and amortization |
277 |
294 |
367 |
| Non-cash interest expense: |
|
|
|
| Related party |
5,631 |
22,073 |
82 |
| Others |
|
394 |
577 |
| Changes in the fair value of derivative instruments: |
|
|
|
| Related party |
(21,957) |
15,988 |
1,853 |
| Others |
(6,739) |
7,663 |
620 |
| Non-cash restructuring charge |
0 |
0 |
0 |
| Non-cash compensation |
315 |
799 |
1,587 |
| Gain on disposal of fixed assets |
|
(1) |
(789) |
| Impairment of purchased technology |
598 |
|
|
| Provision for bad debts |
31 |
|
|
| Changes in assets and liabilities excluding non-cash charges: |
|
|
|
| (Increase) decrease in accounts receivable |
(39) |
145 |
73 |
| (Increase) decrease in inventories |
2 |
(24) |
(20) |
| (Increase) decrease in prepaid expenses and other current assets |
(85) |
(344) |
(95) |
| Increase (decrease) in accounts payable, accrued expenses and other |
(2,488) |
(1,554) |
2,613 |
| Increase in deferred revenue |
58 |
7,072 |
166 |
| Decrease in deferred lease and other liabilities |
(42) |
(35) |
(14) |
| Decrease in restructuring charge |
(300) |
(450) |
(2,130) |
| Total adjustments |
(24,738) |
52,020 |
4,890 |
| Net cash used in operating activities |
(9,687) |
(4,889) |
(11,931) |
| Cash flows from investing activities: |
|
|
|
| Decrease (increase) in restricted cash |
13 |
(1) |
(4) |
| Proceeds from sale of fixed assets |
|
1 |
989 |
| Net cash provided by investing activities |
13 |
|
985 |
| Cash flows from financing activities: |
|
|
|
| Proceeds from notes payable |
|
500 |
|
| Payments on notes payable |
|
(525) |
|
| Proceeds from exercise of stock options and warrants |
242 |
|
|
| Net proceeds from issuance of common stock and warrants |
7,175 |
6,674 |
7,298 |
| Net cash provided by financing activities |
7,417 |
6,649 |
7,298 |
| Net increase (decrease) in cash and cash equivalents |
(2,257) |
1,760 |
(3,648) |
| Cash and cash equivalents, beginning of year |
5,326 |
3,566 |
7,214 |
| Cash and cash equivalents, end of year |
3,069 |
5,326 |
3,566 |
| Supplemental disclosure of cash flow information: |
|
|
|
| Interest paid |
16 |
6 |
|
| Non-cash investing and financing activities: |
|
|
|
| Issuance of liability warrants in connection with common stock offering |
5,138 |
4,920 |
4,523 |
| Reclassification of liability warrants to equity |
349 |
|
|
| Exchange of debt as deferred revenue (Note 8 ) |
|
13,000 |
|
| Common stock issued to settle accrued directors' compensation |
|
$ 10 |
|